Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:CPH)

Fundamentals Snapshot (TSX:CPH)

Bullboard Posts (TSX:CPH)

Q2

Quarter appeared ok, bit down YOY, but lots of very big positives coming down the pipe Not in order of importance: 1)  NCIB...
Northforce13 - 1 day ago

RE:Ez small fast gain available @2.20

No idea if that prediction will bear fruit due to recent developments:  While the wall of shares for sale from MS has dissipated, a...
Northforce13 - August 2, 2022

RE:Ez small fast gain available @2.20

It'll depend on their earnings, which will probably be reported sometime around August 12th. 
DrewJackson - July 30, 2022

Ez small fast gain available @2.20

I think eventually the wall of shares being sold by MS at 2.20 is going to get taken out.  SP will bounce thereafter, one big seller...
Northforce13 - July 26, 2022

RE:RE:RE:RE:RE:Q1

last 4 years revenues are stable, despite declining licensing next two years probably similar, sales down a bit perhaps they will do...
Northforce13 - June 1, 2022

RE:RE:RE:RE:Q1

Thanks for the response. What do you think about Absorica revenue declining? They can't survive on Epuris alone forever.
DrewJackson - June 1, 2022